In agreement with these previous findings, here both miR-101 and VEGF-C interference were shown to independently enhance cisplatin cytotoxicity in bladder cancer cells, and VEGF-C also rescued miR-101’s effect on bladder cancer cell sensitivity to cisplatin. The gene discussed is VEGFC; the disease is urinary bladder cancer.